Cargando…

Neurofibromatosis Type 1 and Chronic Neurological Conditions in the United States: An Administrative Claims Analysis

PURPOSE: Neurofibromatosis Type 1 (NF1) has been linked to several neurological conditions including: epilepsy, Parkinson's disease, headache, multiple sclerosis, and sleep disturbances, predominantly through case reports and series that lack comparison groups. Our objective was to assess wheth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madubata, Chinwe C., Olsen, Margaret A., Stwalley, Dustin L., Gutmann, David H., Johnson, Kimberly J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257895/ https://www.ncbi.nlm.nih.gov/pubmed/24901347 http://dx.doi.org/10.1038/gim.2014.70

Ejemplares similares

915. Prevalence and Treatment of Genital Herpes in a United States Administrative Claims Database
por: Viscidi, Emma, et al.
Publicado: (2023)

Pain symptomology, functional impact, and treatment of people with Neurofibromatosis type 1
por: Buono, Frank D, et al.
Publicado: (2019)

Brain tumors in neurofibromatosis type 1
por: Costa, Amanda De Andrade, et al.
Publicado: (2019)

Motivational Disturbances and Effects of L-dopa Administration in Neurofibromatosis-1 Model Mice
por: Wozniak, David F., et al.
Publicado: (2013)

Increasing Age Has Limited Impact on Risk of Clostridium difficile Infection in an Elderly Population
por: Olsen, Margaret A, et al.
Publicado: (2018)

The burden of clostridium difficile infection: estimates of the incidence of CDI from U.S. Administrative databases
por: Olsen, Margaret A., et al.
Publicado: (2016)

752. Costs Attributable to Clostridioides difficile Infection in the Presence of Differential Mortality
por: Sahrmann, John, et al.
Publicado: (2021)

RAS and beyond: the many faces of the neurofibromatosis type 1 protein
por: Anastasaki, Corina, et al.
Publicado: (2022)

United States Food and Drug Administration’s authorization of reduced exposure claims for IQOS(®): implications for regulation in Latin America
por: Eckford, Robert, et al.
Publicado: (2022)

Increased Incidence and Risk of Septicemia and Urinary Tract Infection After Clostridioides difficile Infection
por: Olsen, Margaret A, et al.
Publicado: (2023)

Putting a stop to nonsense: Revisiting gene correction therapy for neurofibromatosis type 1
por: Gutmann, David H.
Publicado: (2023)

Using the Neurofibromatosis Tumor Predisposition Syndromes to Understand Normal Nervous System Development
por: Garcia, Cynthia, et al.
Publicado: (2014)

Prevalence of Multiple Chronic Conditions Among Medicare Beneficiaries, United States, 2010
por: Lochner, Kimberly A., et al.
Publicado: (2013)

Molecular hydrogen in the treatment of acute and chronic neurological conditions: mechanisms of protection and routes of administration
por: Dohi, Kenji, et al.
Publicado: (2017)

1474. Epidemiology and Outcomes of Hospitalized Patients with Urinary Tract Infections (UTI) Due to Multidrug-Resistant Organisms (MDRO)
por: Lahrman, Frances J, et al.
Publicado: (2019)

Neurofibromatosis Type 1-Associated Optic Pathway Gliomas: Current Challenges and Future Prospects
por: Tang, Yunshuo, et al.
Publicado: (2023)

Laboratory testing for cytomegalovirus among pregnant women in the United States: a retrospective study using administrative claims data
por: Leung, Jessica, et al.
Publicado: (2012)

510. Real-world Effectiveness of Sotrovimab for COVID-19: Evidence from United States (US) Administrative Claims Data
por: Bell, Christopher F, et al.
Publicado: (2023)

914. Incidence of Herpes Zoster and Postherpetic Neuralgia and Herpes Zoster Vaccination in a United States Administrative Claims Database
por: Jain, Purva, et al.
Publicado: (2023)

Updated nomenclature for human and mouse neurofibromatosis type 1 genes
por: Anastasaki, Corina, et al.
Publicado: (2017)

237. Inpatient and Discharge Antibiotic Use for Hospitalized Patients Growing Multi-Drug Resistant Bacteria in Urine Cultures
por: Zou, James, et al.
Publicado: (2020)

Opioid Prescription Claims Among Women of Reproductive Age — United States, 2008–2012
por: Ailes, Elizabeth C., et al.
Publicado: (2015)

Management of Gout in the United States: A Claims‐based Analysis
por: Edwards, N. Lawrence, et al.
Publicado: (2020)

Atrial flutter-related health care use and costs: An analysis of a nationally representative administrative claims database in the United States
por: Deshmukh, Abhishek, et al.
Publicado: (2023)

Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma
por: Ricker, Cora A., et al.
Publicado: (2016)

168. Creation and Internal Validation of a Clinical Predictive Model for Fluconazole Resistance in Patients with Candida Bloodstream Infection
por: Rauseo, Adriana M, et al.
Publicado: (2020)

Predictive Modeling for Clinical Features Associated With Neurofibromatosis Type 1
por: Morris, Stephanie M., et al.
Publicado: (2021)

Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis
por: Sonawane, Kalyani, et al.
Publicado: (2022)

Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis
por: Sonawane, Kalyani, et al.
Publicado: (2022)

Treatment Patterns Among Patients with Psoriatic Arthritis Treated with a Biologic in the United States: Descriptive Analyses from an Administrative Claims Database
por: Walsh, Jessica A., et al.
Publicado: (2018)

Sepsis in the Neurologic Intensive Care Unit: Epidemiology and Outcome
por: Sadaka, Farid, et al.
Publicado: (2015)

Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections
por: Burnham, Jason P, et al.
Publicado: (2018)

The Impact of Bt Corn on Aflatoxin-Related Insurance Claims in the United States
por: Yu, Jina, et al.
Publicado: (2020)

Treatment Patterns of Follicular Lymphoma in the United States: A Claims Analysis
por: Huntington, Scott F., et al.
Publicado: (2022)

Neurofibromatosis Type 1–Associated MPNST State of the Science: Outlining a Research Agenda for the Future
por: Reilly, Karlyne M., et al.
Publicado: (2017)

A Conserved Circadian Function for the Neurofibromatosis 1 Gene
por: Bai, Lei, et al.
Publicado: (2018)

RWD118 Long-Term Neurologic Sequelae Among Patients with Varying COVID-19 Severity: An Administrative Claims Database Analysis
por: Dhangar, I., et al.
Publicado: (2023)

Neurofibromatosis-1 Gene Mutational Profiles Differ Between Syndromic Disease and Sporadic Cancers
por: Bewley, Alice F., et al.
Publicado: (2022)

Creation and Internal Validation of a Clinical Predictive Model for Fluconazole Resistance in Patients With Candida Bloodstream Infection
por: Rauseo, Adriana M, et al.
Publicado: (2022)

Survey design to assess condition of wetlands in the United States
por: Olsen, Anthony R., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qdmcenr962qah1d9j0rgdua1dn